Status:
COMPLETED
Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-Glyc
Lead Sponsor:
Glycardial Diagnostics S.L.
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
The objective of the study is to assess the performance characteristics of Apo J-Glyc as a novel biomarker for the early detection of myocardial ischaemia in patients with suspected acute coronary syn...
Detailed Description
This in vitro diagnosis clinical validation will test the Performance Characteristics of Apo J-Glyc measured with a novel in vitro diagnostic (IVD) test. Blood samples from eligible consenting subject...
Eligibility Criteria
Inclusion
- Age equal or above 18 years old
- Chest pain of suspected cardiac origin
- Signature of informed consent
- Able and willing to comply with study requirements
Exclusion
- Prior inclusion in the same study
- Life expectancy less than 6 months
- Previous inclusion in a therapy-related clinical trial (except clinical trials testing Medical Devices such as stents and/or balloons)
Key Trial Info
Start Date :
August 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
404 Patients enrolled
Trial Details
Trial ID
NCT04119882
Start Date
August 20 2019
End Date
September 20 2021
Last Update
September 28 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
2
Hospital General Universitario Gregorio Marañón
Madrid, Spain
3
Hospital Universitario La Paz
Madrid, Spain
4
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Spain